Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Norway
  4. Oslo Bors
  5. BerGenBio ASA
  6. Financials
    BGBIO   NO0010650013

BERGENBIO ASA

(BGBIO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 1 4611 4872 8101 594--
Entreprise Value (EV)1 1 1001 2342 0891 1921 3831 646
P/E ratio -7,42x-7,10x-9,39x-5,13x-7,05x-5,96x
Yield -----5,55%
Capitalization / Revenue 626x167x4 675x-6,86x11,1x
EV / Revenue 471x139x3 477x-5,95x11,5x
EV / EBITDA -5,66x-6,06x-8,03x-3,83x-7,38x-12,7x
Price to Book 4,22x-3,60x4,29x3,19x-
Nbr of stocks (in thousands) 54 71161 07787 26088 455--
Reference price (NOK) 26,724,432,218,018,018,0
Announcement Date 02/12/201902/11/202002/10/2021---
1 NOK in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 2,348,900,60-233143
EBITDA1 -194-204-260-312-187-130
Operating profit (EBIT)1 -195-204-261-318-232-278
Operating Margin -8 331%-2 297%-43 443%--99,8%-194%
Pre-Tax Profit (EBT)1 -192-199-257-309-228-276
Net income1 -192-199-257-309-228-276
Net margin -8 210%-2 239%-42 767%--98,2%-193%
EPS2 -3,60-3,43-3,43-3,52-2,56-3,03
Dividend per Share2 -----1,00
Announcement Date 02/12/201902/11/202002/10/2021---
1 NOK in Million
2 NOK
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q2 2021 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 ------
EBITDA1 -92,0--71,1-65,0-66,0-66,0
Operating profit (EBIT)1 -92,3-176-71,4-66,0-66,0-66,0
Operating Margin ------
Pre-Tax Profit (EBT)1 -88,9-170-70,5-69,2-65,0-65,0
Net income1 -88,9-170-70,5-69,2-65,0-65,0
Net margin ------
EPS2 -1,02-1,94-0,80-0,81--
Dividend per Share ------
Announcement Date 08/17/202108/17/202111/16/2021---
1 NOK in Million
2 NOK
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 -----52,0
Net Cash position1 360254720402210-
Leverage (Debt / EBITDA) 1,85x1,25x2,77x1,29x1,12x-0,40x
Free Cash Flow1 -187--234-304-340-131
ROE (Net Profit / Equities) -55,8%--57,8%-58,6%-72,3%-
Shareholders' equity1 344-445528316-
ROA (Net Profit / Asset) -50,3%--51,0%-51,8%-127%-396%
Assets1 381-50459717969,8
Book Value Per Share2 6,33-8,954,205,65-
Cash Flow per Share ------
Capex1 0,23-0,072,001,033,00
Capex / Sales 9,76%-11,1%-0,44%2,10%
Announcement Date 02/12/201902/11/202002/10/2021---
1 NOK in Million
2 NOK
Key data
Capitalization (NOK) 1 593 963 695
Capitalization (USD) 173 710 080
Net sales (NOK) 601 000
Net sales (USD) 65 484
Number of employees 46
Sales / Employee (NOK) 13 065
Sales / Employee (USD) 1 424
Free-Float 57,5%
Free-Float capitalization (NOK) 916 192 638
Free-Float capitalization (USD) 99 846 626
Avg. Exchange 20 sessions (NOK) 3 286 048
Avg. Exchange 20 sessions (USD) 358 044
Average Daily Capital Traded 0,21%
EPS & Dividend